Study details
Enrolling now
Expansion and Evaluation of AI-generated Clinical Assessment (AI-COA®) of Depression and Anxiety Severity
Deliberate Solutions Inc.
NCT IDNCT06923995ClinicalTrials.gov data as of Apr 2026
Target enrollment
120
Study length
about 6 months
Ages
18–65
Locations
1 site in TX
About this study
This trial is testing a new way to measure depression and anxiety using artificial intelligence. The goal is to see if this AI tool can provide reliable assessments of mood and anxiety disorders, potentially improving the development of new treatments.
Based on ClinicalTrials.gov records.
What participants do
- 1.AI-driven clinical interview
Primary goalHAM-D ICC
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low6%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: HAM-D ICC
Secondary: HAM-A ICC, MADRS ICC
Body systems
Psychiatry / Mental Health